205 related articles for article (PubMed ID: 31485913)
61. Health-related quality of life and its predictors among patients with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
Sibhat SG; Fenta TG; Sander B; Gebretekle GB
Health Qual Life Outcomes; 2019 Nov; 17(1):165. PubMed ID: 31690327
[TBL] [Abstract][Full Text] [Related]
62. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
Raman S; Ding K; Chow E; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; Haas R; Wiggenraad R; Babington S; Demas WF; Wilson CF; Wong RKS; Zhu L; Brundage M
Qual Life Res; 2018 Apr; 27(4):1089-1098. PubMed ID: 29188483
[TBL] [Abstract][Full Text] [Related]
63. Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.
Demirci S; Eser E; Ozsaran Z; Tankisi D; Aras AB; Ozaydemir G; Anacak Y
Asian Pac J Cancer Prev; 2011; 12(5):1283-7. PubMed ID: 21875283
[TBL] [Abstract][Full Text] [Related]
64. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning.
Petersen MA; Groenvold M; Aaronson NK; Chie WC; Conroy T; Costantini A; Fayers P; Helbostad J; Holzner B; Kaasa S; Singer S; Velikova G; Young T;
Eur J Cancer; 2010 May; 46(8):1352-8. PubMed ID: 20231085
[TBL] [Abstract][Full Text] [Related]
65. The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer.
Rodrigues G; Bezjak A; Osoba D; Catton P; Tsuji D; Taylor D; Warde P
Qual Life Res; 2004 Sep; 13(7):1235-46. PubMed ID: 15473502
[TBL] [Abstract][Full Text] [Related]
66. A validation study of the domains of the core EORTC quality of life questionnaire.
Niezgoda HE; Pater JL
Qual Life Res; 1993 Oct; 2(5):319-25. PubMed ID: 8136796
[TBL] [Abstract][Full Text] [Related]
67. Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life.
Mystakidou K; Tsilika E; Parpa E; Katsouda E; Galanos A; Vlahos L
Qual Life Res; 2005 Oct; 14(8):1825-33. PubMed ID: 16155770
[TBL] [Abstract][Full Text] [Related]
68. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
[TBL] [Abstract][Full Text] [Related]
69. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
[TBL] [Abstract][Full Text] [Related]
70. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group.
Bjordal K; de Graeff A; Fayers PM; Hammerlid E; van Pottelsberghe C; Curran D; Ahlner-Elmqvist M; Maher EJ; Meyza JW; Brédart A; Söderholm AL; Arraras JJ; Feine JS; Abendstein H; Morton RP; Pignon T; Huguenin P; Bottomly A; Kaasa S
Eur J Cancer; 2000 Sep; 36(14):1796-807. PubMed ID: 10974628
[TBL] [Abstract][Full Text] [Related]
71. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
[TBL] [Abstract][Full Text] [Related]
72. Psychometric properties of the EORTC Quality of Life Questionnaire in inpatient cancer rehabilitation in Germany.
Dirmaier J; Zaun S; Koch U; Harfst T; Schulz H
Palliat Support Care; 2004 Jun; 2(2):115-24. PubMed ID: 16594241
[TBL] [Abstract][Full Text] [Related]
73. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
[TBL] [Abstract][Full Text] [Related]
74. Quality of life among Ethiopian cancer patients.
Wondie Y; Hinz A
Support Care Cancer; 2020 Nov; 28(11):5469-5478. PubMed ID: 32170441
[TBL] [Abstract][Full Text] [Related]
75. Health-related quality of life among prostate cancer patients: real-life situation at the beginning of treatment.
Bergius S; Torvinen S; Muhonen T; Roine RP; Sintonen H; Taari K
Scand J Urol; 2017 Feb; 51(1):13-19. PubMed ID: 27809631
[TBL] [Abstract][Full Text] [Related]
76. The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy.
Kaasa S; Bjordal K; Aaronson N; Moum T; Wist E; Hagen S; Kvikstad A
Eur J Cancer; 1995 Dec; 31A(13-14):2260-3. PubMed ID: 8652253
[TBL] [Abstract][Full Text] [Related]
77. Analysis of Quality of Life Subjective Perception by Patients Treated for Prostate Cancer with the EORTC QLQ-C30 Questionnaire and QLQ-PR25 Module.
Dąbrowska-Bender M; Słoniewski R; Religioni U; Juszczyk G; Słoniewska A; Staniszewska A
J Cancer Educ; 2017 Sep; 32(3):509-515. PubMed ID: 26614256
[TBL] [Abstract][Full Text] [Related]
78. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
[TBL] [Abstract][Full Text] [Related]
79. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
[TBL] [Abstract][Full Text] [Related]
80. The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set.
King MT; Norman R; Mercieca-Bebber R; Costa DSJ; McTaggart-Cowan H; Peacock S; Janda M; Müller F; Viney R; Pickard AS; Cella D;
Value Health; 2021 Jun; 24(6):862-873. PubMed ID: 34119085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
